|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.50 EUR | -1.17% |
|
+1.66% | -5.59% |
| 07-29 | Virbac, without the alibi |  |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 411.88 | +22.04% | 8 | ||||||
| 111.94 | +44.83% | 17 | ||||||
| 30.07 | +14.04% | 14 | ||||||
| - | 17.35 | +106.06% | 2 | |||||
| 3.304 | +5.61% | 6 | ||||||
| 14.42 | +14.08% | 4 | ||||||
| - | 45 | +23.86% | 5 | |||||
| 20.41 | +19.92% | 3 | ||||||
| 9 | +37.61% | 2 | ||||||
| 90.38 | +23.8% | 4 | ||||||
| 18.5 | +41.98% | 2 | ||||||
| 14.75 | +41.96% | 2 | ||||||
| 39.5 | +79.55% | 2 | ||||||
| Average | 63.58 | +36.56% | 5 | ||||||
| Weighted average by Cap. | 90.38 | +37.53% | 13 |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
